Healthcare Triangle is trading 5.31% down at $0.89; no reliable company-specific announcement for August 21, 2026 directly explains the decline.
- The stock is extending a sharp post-August 13 reversal after its Q2 revenue announcement reported 158% year-over-year growth.
- Prior share issuances and approved financing flexibility may keep dilution concerns in focus.
- These developments do not establish a direct cause for August 21’s move.